Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled studyJohn F. Greden, Bryan Dechairo, Boadie W. Dunlop et al.|Journal of Psychiatric Research|2019Cited by 346
Impact of Pharmacogenomics on Clinical Outcomes for Patients Taking Medications With Gene-Drug Interactions in a Randomized Controlled TrialMichael E. Thase, John F. Greden, Sagar V. Parikh et al.|The Journal of Clinical Psychiatry|2019Cited by 72